Attitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia
Clinical Schizophrenia & Related Psychoses · 2018-03 · 12 (1) · 12-22
DOI: 10.3371/csrp.casc.070415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Schizophrenia & Related Psychoses, 2018-03. Verfasst von Angela H. Campbell und 6 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
The determinants of attitudes toward medication (ATM) are not well elucidated. In particular, literature remains equivocal regarding the influence of cognition, adverse events, and psychiatric symptomatology. This study evaluated relationships between those outcomes in schizophrenia and ATM. This is a retrospective analysis of data collected during the Texas Medication Algorithm Project (TMAP, n=307 with schizophrenia-related diagnoses), in outpatient clinics at baseline and every 3 months for ≥1 year (for cognition: 3rd and 9th month only). The Drug Attitude Inventory (DAI-30) measured ATM, and independent variables were: cognition (Trail Making Test [TMT], Verbal Fluency Test, Hopkins Verbal Learning Test), adverse events (Systematic Assessment for Treatment-Emergent Adverse Events, Barnes Akathisia Rating Scale), psychiatric symptomatology (Brief Psychiatric Rating Scale, Scale for Assessment of Negative Symptoms [SANS]), and medication adherence (Medication Compliance Scale). Analyses included binary logistic regression (cognition, psychiatric symptoms) and chi-square (adverse events, adherence) for baseline comparisons, and linear regression (cognition) or ANOVA (adverse events, adherence) for changes over time. Mean DAI-30 scores did not change over 12 months. Odds of positive ATM increased with higher TMT Part B scores (p=0.03) and lower SANS scores (p=0.02). Worsening of general psychopathology (p
Zitieren
APA
Campbell, A. H., Scalo, J. F., Crismon, M. L., Barner, J. C., Argo, T. R., Lawson, K. A., & Miller, A. (2018). Attitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia. Clinical Schizophrenia & Related Psychoses, 12(1), 12-22. https://doi.org/10.3371/csrp.casc.070415
Vancouver
Campbell AH, Scalo JF, Crismon ML, Barner JC, Argo TR, Lawson KA, et al. Attitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia. Clinical Schizophrenia & Related Psychoses. 2018;12(1):12-22. doi:10.3371/csrp.casc.070415
BibTeX
@article{Campbell2018,
author = {Campbell, Angela H. and Scalo, Julieta F. and Crismon, M. Lynn and Barner, Jamie C. and Argo, Tami R. and Lawson, Kenneth A. and Miller, Alexander},
title = {Attitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia},
journal = {Clinical Schizophrenia & Related Psychoses},
year = {2018},
volume = {12},
number = {1},
pages = {12--22},
doi = {10.3371/csrp.casc.070415}
}
EUVIMED